Mark Vrana

1.8k total citations
16 papers, 415 citations indexed

About

Mark Vrana is a scholar working on Molecular Biology, Nutrition and Dietetics and Organic Chemistry. According to data from OpenAlex, Mark Vrana has authored 16 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Nutrition and Dietetics and 5 papers in Organic Chemistry. Recurrent topics in Mark Vrana's work include Glycosylation and Glycoproteins Research (8 papers), Microbial Metabolites in Food Biotechnology (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Mark Vrana is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Microbial Metabolites in Food Biotechnology (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Mark Vrana collaborates with scholars based in United States. Mark Vrana's co-authors include Michael Potter, Stuart Rudikoff, William Humphrey, R Lieberman, George F. Gray, Hollon W. Farr, E. B. Mushinski, Michael P. Lardis, Cornelis P.J. Glaudemans and Lloyd J. Old and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Mark Vrana

16 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Vrana United States	12	206	155	122	84	61	16	415
Shoichi Oboshi Japan	10	139 0.7×	30 0.2×	42 0.3×	34 0.4×	28 0.5×	36	357
N. I. Khramkova Russia	5	165 0.8×	50 0.3×	62 0.5×	88 1.0×	6 0.1×	9	478
D. Shoham Israel	10	109 0.5×	59 0.4×	191 1.6×	24 0.3×	6 0.1×	14	428
R R Skelly United States	8	172 0.8×	68 0.4×	248 2.0×	22 0.3×	5 0.1×	16	473
Isamu Sugawara Japan	7	100 0.5×	43 0.3×	92 0.8×	16 0.2×	7 0.1×	22	341
Fumimaro Takaku Japan	8	107 0.5×	43 0.3×	194 1.6×	31 0.4×	17 0.3×	11	442
Karin Kissel Germany	11	120 0.6×	58 0.4×	249 2.0×	33 0.4×	7 0.1×	16	578
Etsuko Hattori Japan	12	137 0.7×	15 0.1×	70 0.6×	138 1.6×	48 0.8×	34	530
R. Standring United Kingdom	10	126 0.6×	116 0.7×	87 0.7×	35 0.4×	4 0.1×	27	483
Joyce Lübbers Netherlands	9	201 1.0×	45 0.3×	260 2.1×	38 0.5×	8 0.1×	14	515

Countries citing papers authored by Mark Vrana

Since Specialization

Citations

This map shows the geographic impact of Mark Vrana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vrana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vrana more than expected).

Fields of papers citing papers by Mark Vrana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Vrana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vrana. The network helps show where Mark Vrana may publish in the future.

Co-authorship network of co-authors of Mark Vrana

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Vrana. A scholar is included among the top collaborators of Mark Vrana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Vrana. Mark Vrana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Robinson, Jennifer L., Manshan Xu, Mark Vrana, et al.. (2018). Estrogen Promotes Mandibular Condylar Fibrocartilage Chondrogenesis and Inhibits Degeneration via Estrogen Receptor Alpha in Female Mice. Scientific Reports. 8(1). 28 indexed citations

Kaufman, Jonathan L., Ajay K. Nooka, Mark Vrana, et al.. (2010). Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma. Cancer. 116(13). 3143–3151. 27 indexed citations

Vrana, Mark & Paul A. Bunn. (1980). A Review of Therapeutic Trials in Multiple Myeloma and Perspectives for Future Trials. Elsevier eBooks. 239–262. 3 indexed citations

Vrana, Mark, Stuart Rudikoff, & M Potter. (1979). The structural basis of a hapten-inhibitable kappa-chain idiotype.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 122(5). 1905–10. 19 indexed citations

Vrana, Mark, Stuart Rudikoff, & Michael Potter. (1979). The Structural Basis of a Hapten-Inhibitable κ-Chain Idiotype. The Journal of Immunology. 122(5). 1905–1910. 16 indexed citations

Vrana, Mark, Stuart Rudikoff, & Michael Potter. (1978). Sequence variation among heavy chains from inulin-binding myeloma proteins. Proceedings of the National Academy of Sciences. 75(4). 1957–1961. 24 indexed citations

Vrana, Mark, et al.. (1978). Binding Studies on Heavy-Light Chain Recombinant Hybrid Immunoglobulins a Derived from Murine Myeloma Anti-Fructofuranans. The Journal of Immunology. 120(2). 408–410. 10 indexed citations

Glaudemans, Cornelis P.J., Manoja Kumar Das, & Mark Vrana. (1978). [33] Homogeneous murine immunoglobulins with anticarbohydrate specificity. Methods in enzymology on CD-ROM/Methods in enzymology. 50. 316–323. 5 indexed citations

Lieberman, R, et al.. (1977). Idiotypes of inulin-binding myeloma proteins localized to variable region light and heavy chains: genetic significance.. The Journal of Experimental Medicine. 146(5). 1294–1304. 21 indexed citations

10.

Vrana, Mark, Stuart Rudikoff, & Michael Potter. (1977). Heavy-chain variable-region sequence from an inulin-binding myeloma protein. Biochemistry. 16(6). 1170–1175. 10 indexed citations

11.

Potter, Michael J., Stuart Rudikoff, Mark Vrana, Desirazu N. Rao, & E. B. Mushinski. (1977). Primary Structural Differences in Myeloma Proteins That Bind the Same Haptens. Cold Spring Harbor Symposia on Quantitative Biology. 41(0). 661–666. 12 indexed citations

12.

Vrana, Mark, Jelka Tomašić, & Cornelis P.J. Glaudemans. (1976). Purification of Homogeneous Murine Immunoglobulins with Anti-Fructofuranan Specificity. The Journal of Immunology. 116(6). 1662–1663. 21 indexed citations

13.

Lieberman, R, Michael Potter, William Humphrey, E. B. Mushinski, & Mark Vrana. (1975). Multiple individual and cross-specific indiotypes on 13 levan-binding myeloma proteins of BALB/c mice.. The Journal of Experimental Medicine. 142(1). 106–119. 82 indexed citations

14.

Farr, Hollon W., et al.. (1973). Extracranial meningioma. Journal of Surgical Oncology. 5(5). 411–420. 74 indexed citations

15.

Old, Lloyd J., et al.. (1972). A Fetal Antigen Associated with Human Neoplasia. New England Journal of Medicine. 286(22). 1178–1183. 48 indexed citations

16.

Lardis, Michael P., et al.. (1971). Antigenic changes in human breast neoplasia. Cancer. 28(6). 1457–1461. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact